Metastatic patterns of extremity myxoid liposarcoma and their outcome

Background and Objectives Extremity myxoid liposarcomas have a unique extrapulmonary metastatic potential. We studied the metastatic pattern of extremity liposarcomas to determine what types of post‐treatment imaging may be of value in the follow‐up these patients. Methods Twenty‐two patients from a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of surgical oncology 2002-06, Vol.80 (2), p.89-93
Hauptverfasser: Estourgie, Susanne H., Nielsen, Gunnlaugur P., Ott, Mark J.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 93
container_issue 2
container_start_page 89
container_title Journal of surgical oncology
container_volume 80
creator Estourgie, Susanne H.
Nielsen, Gunnlaugur P.
Ott, Mark J.
description Background and Objectives Extremity myxoid liposarcomas have a unique extrapulmonary metastatic potential. We studied the metastatic pattern of extremity liposarcomas to determine what types of post‐treatment imaging may be of value in the follow‐up these patients. Methods Twenty‐two patients from a total of 128 patients with primary extremity liposarcoma were treated at a tertiary care institution for subsequent metastases from January 1981 to January 2000. Median follow‐up was 45 months (range: 6–270 months). Data on these patients was prospectively collected and then retrospectively analyzed for effect of metastatic pattern and treatment on outcome. Results Of these 22 patients, extrapulmonary metastases developed in 10, combined pulmonary and extrapulmonary metastases developed in 6, and isolated pulmonary metastases developed in 6. Of the 16 patients with extrapulmonary metastases, 13 were of the myxoid subtype. Of the 49 patients with extremity myxoid liposarcomas, metastases developed in 14 (29%). The most common sites of metastases among these 14 patients include: the retroperitoneum, 10 patients (71)%; intra‐abdominal extrahepatic, 7 patients (50%); spinal/paraspinal, 6 patients (43%). Only 3 of the patients are alive and disease free and all 3 of these patients are from the subgroup of 10 patients with only extra‐pulmonary metastases (2 intra‐abdominal and 1 retroperitoneal). Conclusions Extremity myxoid liposarcomas have an unusually high predilection for extra‐pulmonary metastases, frequently without any pulmonary metastases. After treatment of the primary tumor, these patients should be followed with periodic chest X‐ray and abdominal/pelvic computed tomography (CT) scans. Any back or neurologic complaints should prompt additional imaging of the appropriate spinal area. Consideration should be given to surgical and adjuvant treatment of metastatic disease when appropriate. J. Surg. Oncol. 2002;80:89–93. © 2002 Wiley‐Liss, Inc.
doi_str_mv 10.1002/jso.10093
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71985624</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>71985624</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3593-d43f510464a16fad098915c9848a45688f1f653e49874f928b3b4de6928585b3</originalsourceid><addsrcrecordid>eNp1kM1OAjEUhRujEUQXvoCZlYmLkXb6M-3SGEQNAkYSEjdNmenE4gzFtkR4e4ugrlzdk3u_c3JzADhH8BpBmHXn3m6FwAegjaBgqYCCH4J2vGUpyQVsgRPv5zAigpFj0EIZyjHmtA16TzooH1QwRbJUIWi38ImtEr0OTjcmbJJms7amTGqztF65wjYqUYsyCW_auMSuQtzoU3BUqdrrs_3sgMldb3J7nw5G_Yfbm0FaYCpwWhJcUQQJIwqxSpXxS4FoITjhilDGeYUqRrEmguekEhmf4RkpNYuKcjrDHXC5i106-7HSPsjG-ELXtVpou_IyR4JTlpEIXu3Awlnvna7k0plGuY1EUG4rk7Ey-V1ZZC_2oatZo8s_ct9RBLo74NPUevN_knx8Gf1EpjuH8UGvfx3KvUuW45zK6bAvx8N8PHmdTOUz_gKmbYR1</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71985624</pqid></control><display><type>article</type><title>Metastatic patterns of extremity myxoid liposarcoma and their outcome</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Estourgie, Susanne H. ; Nielsen, Gunnlaugur P. ; Ott, Mark J.</creator><creatorcontrib>Estourgie, Susanne H. ; Nielsen, Gunnlaugur P. ; Ott, Mark J.</creatorcontrib><description>Background and Objectives Extremity myxoid liposarcomas have a unique extrapulmonary metastatic potential. We studied the metastatic pattern of extremity liposarcomas to determine what types of post‐treatment imaging may be of value in the follow‐up these patients. Methods Twenty‐two patients from a total of 128 patients with primary extremity liposarcoma were treated at a tertiary care institution for subsequent metastases from January 1981 to January 2000. Median follow‐up was 45 months (range: 6–270 months). Data on these patients was prospectively collected and then retrospectively analyzed for effect of metastatic pattern and treatment on outcome. Results Of these 22 patients, extrapulmonary metastases developed in 10, combined pulmonary and extrapulmonary metastases developed in 6, and isolated pulmonary metastases developed in 6. Of the 16 patients with extrapulmonary metastases, 13 were of the myxoid subtype. Of the 49 patients with extremity myxoid liposarcomas, metastases developed in 14 (29%). The most common sites of metastases among these 14 patients include: the retroperitoneum, 10 patients (71)%; intra‐abdominal extrahepatic, 7 patients (50%); spinal/paraspinal, 6 patients (43%). Only 3 of the patients are alive and disease free and all 3 of these patients are from the subgroup of 10 patients with only extra‐pulmonary metastases (2 intra‐abdominal and 1 retroperitoneal). Conclusions Extremity myxoid liposarcomas have an unusually high predilection for extra‐pulmonary metastases, frequently without any pulmonary metastases. After treatment of the primary tumor, these patients should be followed with periodic chest X‐ray and abdominal/pelvic computed tomography (CT) scans. Any back or neurologic complaints should prompt additional imaging of the appropriate spinal area. Consideration should be given to surgical and adjuvant treatment of metastatic disease when appropriate. J. Surg. Oncol. 2002;80:89–93. © 2002 Wiley‐Liss, Inc.</description><identifier>ISSN: 0022-4790</identifier><identifier>EISSN: 1096-9098</identifier><identifier>DOI: 10.1002/jso.10093</identifier><identifier>PMID: 12173385</identifier><language>eng</language><publisher>New York: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>abdominal ; Abdominal Neoplasms - secondary ; Extremities ; Humans ; liposarcoma ; Liposarcoma, Myxoid - mortality ; Liposarcoma, Myxoid - secondary ; Liver Neoplasms - secondary ; Lung Neoplasms - secondary ; Neoplasm Recurrence, Local - mortality ; Outcome Assessment (Health Care) ; paraspinal ; retroperitoneal ; Retroperitoneal Neoplasms - secondary ; Soft Tissue Neoplasms - mortality ; Soft Tissue Neoplasms - pathology ; Spinal Neoplasms - secondary ; Survival Rate</subject><ispartof>Journal of surgical oncology, 2002-06, Vol.80 (2), p.89-93</ispartof><rights>Copyright © 2002 Wiley‐Liss, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3593-d43f510464a16fad098915c9848a45688f1f653e49874f928b3b4de6928585b3</citedby><cites>FETCH-LOGICAL-c3593-d43f510464a16fad098915c9848a45688f1f653e49874f928b3b4de6928585b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fjso.10093$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fjso.10093$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27903,27904,45553,45554</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12173385$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Estourgie, Susanne H.</creatorcontrib><creatorcontrib>Nielsen, Gunnlaugur P.</creatorcontrib><creatorcontrib>Ott, Mark J.</creatorcontrib><title>Metastatic patterns of extremity myxoid liposarcoma and their outcome</title><title>Journal of surgical oncology</title><addtitle>J. Surg. Oncol</addtitle><description>Background and Objectives Extremity myxoid liposarcomas have a unique extrapulmonary metastatic potential. We studied the metastatic pattern of extremity liposarcomas to determine what types of post‐treatment imaging may be of value in the follow‐up these patients. Methods Twenty‐two patients from a total of 128 patients with primary extremity liposarcoma were treated at a tertiary care institution for subsequent metastases from January 1981 to January 2000. Median follow‐up was 45 months (range: 6–270 months). Data on these patients was prospectively collected and then retrospectively analyzed for effect of metastatic pattern and treatment on outcome. Results Of these 22 patients, extrapulmonary metastases developed in 10, combined pulmonary and extrapulmonary metastases developed in 6, and isolated pulmonary metastases developed in 6. Of the 16 patients with extrapulmonary metastases, 13 were of the myxoid subtype. Of the 49 patients with extremity myxoid liposarcomas, metastases developed in 14 (29%). The most common sites of metastases among these 14 patients include: the retroperitoneum, 10 patients (71)%; intra‐abdominal extrahepatic, 7 patients (50%); spinal/paraspinal, 6 patients (43%). Only 3 of the patients are alive and disease free and all 3 of these patients are from the subgroup of 10 patients with only extra‐pulmonary metastases (2 intra‐abdominal and 1 retroperitoneal). Conclusions Extremity myxoid liposarcomas have an unusually high predilection for extra‐pulmonary metastases, frequently without any pulmonary metastases. After treatment of the primary tumor, these patients should be followed with periodic chest X‐ray and abdominal/pelvic computed tomography (CT) scans. Any back or neurologic complaints should prompt additional imaging of the appropriate spinal area. Consideration should be given to surgical and adjuvant treatment of metastatic disease when appropriate. J. Surg. Oncol. 2002;80:89–93. © 2002 Wiley‐Liss, Inc.</description><subject>abdominal</subject><subject>Abdominal Neoplasms - secondary</subject><subject>Extremities</subject><subject>Humans</subject><subject>liposarcoma</subject><subject>Liposarcoma, Myxoid - mortality</subject><subject>Liposarcoma, Myxoid - secondary</subject><subject>Liver Neoplasms - secondary</subject><subject>Lung Neoplasms - secondary</subject><subject>Neoplasm Recurrence, Local - mortality</subject><subject>Outcome Assessment (Health Care)</subject><subject>paraspinal</subject><subject>retroperitoneal</subject><subject>Retroperitoneal Neoplasms - secondary</subject><subject>Soft Tissue Neoplasms - mortality</subject><subject>Soft Tissue Neoplasms - pathology</subject><subject>Spinal Neoplasms - secondary</subject><subject>Survival Rate</subject><issn>0022-4790</issn><issn>1096-9098</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kM1OAjEUhRujEUQXvoCZlYmLkXb6M-3SGEQNAkYSEjdNmenE4gzFtkR4e4ugrlzdk3u_c3JzADhH8BpBmHXn3m6FwAegjaBgqYCCH4J2vGUpyQVsgRPv5zAigpFj0EIZyjHmtA16TzooH1QwRbJUIWi38ImtEr0OTjcmbJJms7amTGqztF65wjYqUYsyCW_auMSuQtzoU3BUqdrrs_3sgMldb3J7nw5G_Yfbm0FaYCpwWhJcUQQJIwqxSpXxS4FoITjhilDGeYUqRrEmguekEhmf4RkpNYuKcjrDHXC5i106-7HSPsjG-ELXtVpou_IyR4JTlpEIXu3Awlnvna7k0plGuY1EUG4rk7Ey-V1ZZC_2oatZo8s_ct9RBLo74NPUevN_knx8Gf1EpjuH8UGvfx3KvUuW45zK6bAvx8N8PHmdTOUz_gKmbYR1</recordid><startdate>200206</startdate><enddate>200206</enddate><creator>Estourgie, Susanne H.</creator><creator>Nielsen, Gunnlaugur P.</creator><creator>Ott, Mark J.</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200206</creationdate><title>Metastatic patterns of extremity myxoid liposarcoma and their outcome</title><author>Estourgie, Susanne H. ; Nielsen, Gunnlaugur P. ; Ott, Mark J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3593-d43f510464a16fad098915c9848a45688f1f653e49874f928b3b4de6928585b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>abdominal</topic><topic>Abdominal Neoplasms - secondary</topic><topic>Extremities</topic><topic>Humans</topic><topic>liposarcoma</topic><topic>Liposarcoma, Myxoid - mortality</topic><topic>Liposarcoma, Myxoid - secondary</topic><topic>Liver Neoplasms - secondary</topic><topic>Lung Neoplasms - secondary</topic><topic>Neoplasm Recurrence, Local - mortality</topic><topic>Outcome Assessment (Health Care)</topic><topic>paraspinal</topic><topic>retroperitoneal</topic><topic>Retroperitoneal Neoplasms - secondary</topic><topic>Soft Tissue Neoplasms - mortality</topic><topic>Soft Tissue Neoplasms - pathology</topic><topic>Spinal Neoplasms - secondary</topic><topic>Survival Rate</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Estourgie, Susanne H.</creatorcontrib><creatorcontrib>Nielsen, Gunnlaugur P.</creatorcontrib><creatorcontrib>Ott, Mark J.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of surgical oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Estourgie, Susanne H.</au><au>Nielsen, Gunnlaugur P.</au><au>Ott, Mark J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Metastatic patterns of extremity myxoid liposarcoma and their outcome</atitle><jtitle>Journal of surgical oncology</jtitle><addtitle>J. Surg. Oncol</addtitle><date>2002-06</date><risdate>2002</risdate><volume>80</volume><issue>2</issue><spage>89</spage><epage>93</epage><pages>89-93</pages><issn>0022-4790</issn><eissn>1096-9098</eissn><abstract>Background and Objectives Extremity myxoid liposarcomas have a unique extrapulmonary metastatic potential. We studied the metastatic pattern of extremity liposarcomas to determine what types of post‐treatment imaging may be of value in the follow‐up these patients. Methods Twenty‐two patients from a total of 128 patients with primary extremity liposarcoma were treated at a tertiary care institution for subsequent metastases from January 1981 to January 2000. Median follow‐up was 45 months (range: 6–270 months). Data on these patients was prospectively collected and then retrospectively analyzed for effect of metastatic pattern and treatment on outcome. Results Of these 22 patients, extrapulmonary metastases developed in 10, combined pulmonary and extrapulmonary metastases developed in 6, and isolated pulmonary metastases developed in 6. Of the 16 patients with extrapulmonary metastases, 13 were of the myxoid subtype. Of the 49 patients with extremity myxoid liposarcomas, metastases developed in 14 (29%). The most common sites of metastases among these 14 patients include: the retroperitoneum, 10 patients (71)%; intra‐abdominal extrahepatic, 7 patients (50%); spinal/paraspinal, 6 patients (43%). Only 3 of the patients are alive and disease free and all 3 of these patients are from the subgroup of 10 patients with only extra‐pulmonary metastases (2 intra‐abdominal and 1 retroperitoneal). Conclusions Extremity myxoid liposarcomas have an unusually high predilection for extra‐pulmonary metastases, frequently without any pulmonary metastases. After treatment of the primary tumor, these patients should be followed with periodic chest X‐ray and abdominal/pelvic computed tomography (CT) scans. Any back or neurologic complaints should prompt additional imaging of the appropriate spinal area. Consideration should be given to surgical and adjuvant treatment of metastatic disease when appropriate. J. Surg. Oncol. 2002;80:89–93. © 2002 Wiley‐Liss, Inc.</abstract><cop>New York</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>12173385</pmid><doi>10.1002/jso.10093</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-4790
ispartof Journal of surgical oncology, 2002-06, Vol.80 (2), p.89-93
issn 0022-4790
1096-9098
language eng
recordid cdi_proquest_miscellaneous_71985624
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects abdominal
Abdominal Neoplasms - secondary
Extremities
Humans
liposarcoma
Liposarcoma, Myxoid - mortality
Liposarcoma, Myxoid - secondary
Liver Neoplasms - secondary
Lung Neoplasms - secondary
Neoplasm Recurrence, Local - mortality
Outcome Assessment (Health Care)
paraspinal
retroperitoneal
Retroperitoneal Neoplasms - secondary
Soft Tissue Neoplasms - mortality
Soft Tissue Neoplasms - pathology
Spinal Neoplasms - secondary
Survival Rate
title Metastatic patterns of extremity myxoid liposarcoma and their outcome
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T11%3A24%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Metastatic%20patterns%20of%20extremity%20myxoid%20liposarcoma%20and%20their%20outcome&rft.jtitle=Journal%20of%20surgical%20oncology&rft.au=Estourgie,%20Susanne%20H.&rft.date=2002-06&rft.volume=80&rft.issue=2&rft.spage=89&rft.epage=93&rft.pages=89-93&rft.issn=0022-4790&rft.eissn=1096-9098&rft_id=info:doi/10.1002/jso.10093&rft_dat=%3Cproquest_cross%3E71985624%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=71985624&rft_id=info:pmid/12173385&rfr_iscdi=true